Cargando…
Development of T cell immunity to norovirus and rotavirus in children under five years of age
Most of the research effort to understand protective immunity against norovirus (NoV) has focused on humoral immunity, whereas immunity against another major pediatric enteric virus, rotavirus (RV), has been studied more thoroughly. The aim of this study was to investigate development of cell-mediat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397277/ https://www.ncbi.nlm.nih.gov/pubmed/30824789 http://dx.doi.org/10.1038/s41598-019-39840-9 |
_version_ | 1783399398265323520 |
---|---|
author | Malm, Maria Hyöty, Heikki Knip, Mikael Vesikari, Timo Blazevic, Vesna |
author_facet | Malm, Maria Hyöty, Heikki Knip, Mikael Vesikari, Timo Blazevic, Vesna |
author_sort | Malm, Maria |
collection | PubMed |
description | Most of the research effort to understand protective immunity against norovirus (NoV) has focused on humoral immunity, whereas immunity against another major pediatric enteric virus, rotavirus (RV), has been studied more thoroughly. The aim of this study was to investigate development of cell-mediated immunity to NoV in early childhood. Immune responses to NoV GI.3 and GII.4 virus-like particles and RV VP6 were determined in longitudinal blood samples of 10 healthy children from three months to four years of age. Serum IgG antibodies were measured using enzyme-linked immunosorbent assay and production of interferon-gamma by peripheral blood T cells was analyzed by enzyme-linked immunospot assay. NoV-specific T cells were detected in eight of 10 children by the age of four, with some individual variation. T cell responses to NoV GII.4 were higher than those to GI.3, but these responses were generally lower than responses to RV VP6. In contrast to NoV-specific antibodies, T cell responses were transient in nature. No correlation between cell-mediated and antibody responses was observed. NoV exposure induces vigorous T cell responses in children under five years of age, similar to RV. A role of T cells in protection from NoV infection in early childhood warrants further investigation. |
format | Online Article Text |
id | pubmed-6397277 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63972772019-03-05 Development of T cell immunity to norovirus and rotavirus in children under five years of age Malm, Maria Hyöty, Heikki Knip, Mikael Vesikari, Timo Blazevic, Vesna Sci Rep Article Most of the research effort to understand protective immunity against norovirus (NoV) has focused on humoral immunity, whereas immunity against another major pediatric enteric virus, rotavirus (RV), has been studied more thoroughly. The aim of this study was to investigate development of cell-mediated immunity to NoV in early childhood. Immune responses to NoV GI.3 and GII.4 virus-like particles and RV VP6 were determined in longitudinal blood samples of 10 healthy children from three months to four years of age. Serum IgG antibodies were measured using enzyme-linked immunosorbent assay and production of interferon-gamma by peripheral blood T cells was analyzed by enzyme-linked immunospot assay. NoV-specific T cells were detected in eight of 10 children by the age of four, with some individual variation. T cell responses to NoV GII.4 were higher than those to GI.3, but these responses were generally lower than responses to RV VP6. In contrast to NoV-specific antibodies, T cell responses were transient in nature. No correlation between cell-mediated and antibody responses was observed. NoV exposure induces vigorous T cell responses in children under five years of age, similar to RV. A role of T cells in protection from NoV infection in early childhood warrants further investigation. Nature Publishing Group UK 2019-03-01 /pmc/articles/PMC6397277/ /pubmed/30824789 http://dx.doi.org/10.1038/s41598-019-39840-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Malm, Maria Hyöty, Heikki Knip, Mikael Vesikari, Timo Blazevic, Vesna Development of T cell immunity to norovirus and rotavirus in children under five years of age |
title | Development of T cell immunity to norovirus and rotavirus in children under five years of age |
title_full | Development of T cell immunity to norovirus and rotavirus in children under five years of age |
title_fullStr | Development of T cell immunity to norovirus and rotavirus in children under five years of age |
title_full_unstemmed | Development of T cell immunity to norovirus and rotavirus in children under five years of age |
title_short | Development of T cell immunity to norovirus and rotavirus in children under five years of age |
title_sort | development of t cell immunity to norovirus and rotavirus in children under five years of age |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397277/ https://www.ncbi.nlm.nih.gov/pubmed/30824789 http://dx.doi.org/10.1038/s41598-019-39840-9 |
work_keys_str_mv | AT malmmaria developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage AT hyotyheikki developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage AT knipmikael developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage AT vesikaritimo developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage AT blazevicvesna developmentoftcellimmunitytonorovirusandrotavirusinchildrenunderfiveyearsofage |